| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Over the past 90 days, insiders at Cytomx Therapeutics, Inc. (CTMX) have been net sellers, shedding 1,624 shares worth roughly $5K on balance.
CTMX sits in the Biotechnology industry within the Health Care sector, so this activity is best read against the sector's broader insider trend.
| Role | Insider | Shares | Value | 30d |
|---|---|---|---|---|
| CEO | 987.9K | $3.42M | - | |
| Other | 650.0K | $2.25M | - | |
| CFO | 295.3K | $1.02M | - | |
| Other | 100.0K | $346.0K | - | |
| Other | 87.5K | $302.8K | - |
Buys and sells only
| Date | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|
| Jan 5, 2018 | McCarthy Sean A.67 | President And CEO | Sale+OE | 6,526 | $25.01 | $163,215.26 | -58.4% | |
| Jan 2, 2018 | McCarthy Sean A.67 | President And CEO | Sale+OE | 13,052 | $21.04 | $274,614.08 | -73.8% | |
| Jan 2, 2018 | Ray Debanjan | Chief Financial Officer | Sell | 2,500 | $21.11 | $52,775.00 | -25.5% | |
| Dec 26, 2017 | Gluck Frederick W | Director | Sell | 5,000 | $22.29 | $111,425.50 | -1.6% | |
| Dec 1, 2017 | Ray Debanjan | Chief Financial Officer | Sell | 2,500 | $20.58 | $51,450.00 | -20.3% | |
| Dec 1, 2017 | McCarthy Sean A.67 | President And CEO | Sale+OE | 14,340 | $20.60 | $295,404.00 | -75.5% | |
| Nov 1, 2017 | McCarthy Sean A.67 | President And CEO | Sale+OE | 14,342 | $19.86 | $284,832.12 | -77.2% | |
| Nov 1, 2017 | Ray Debanjan | Chief Financial Officer | Sell | 2,500 | $20.00 | $50,000.00 | -17.1% | |
| Oct 4, 2017 | McCarthy Sean A.67 | President And CEO | Sale+OE | 19,120 | $24.13 | $461,365.60 | -81.8% | |
| Oct 4, 2017 | Kavanaugh William Michael | CSO, Head Res.&Non-clin. Dev. | Sale+OE | 48,368 | $24.34 | $1,177,277.12 | -77.7% |